Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

OBJECTIVE: We characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination. METHODS: We evaluated clinical phenotypes, annualised relapse rates (ARR) prior and on immunotherapy and Expanded Disabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanathan, Sudarshini, Mohammad, Shekeeb, Tantsis, Esther, Nguyen, Tina Kim, Merheb, Vera, Fung, Victor S C, White, Owen Bruce, Broadley, Simon, Lechner-Scott, Jeannette, Vucic, Steve, Henderson, Andrew P D, Barnett, Michael Harry, Reddel, Stephen W, Brilot, Fabienne, Dale, Russell C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Neuro-Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800335/
https://www.ncbi.nlm.nih.gov/pubmed/29142145
http://dx.doi.org/10.1136/jnnp-2017-316880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800335/
https://www.ncbi.nlm.nih.gov/pubmed/29142145
http://dx.doi.org/10.1136/jnnp-2017-316880

Ejemplares similares